← Back to Search

Amino Acid

L-Lysine for Type 2 Diabetes

Phase 1

Waitlist Available

Led By Jane Ferguson, PhD

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 6 hours post-lysine administration

Awards & highlights

Study Summary

This trial looks at whether taking lysine supplements affects the levels of a compound called 2-AAA in the blood.

Eligible Conditions

Type 2 Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 6 hours post-lysine administration

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 6 hours post-lysine administration

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 hours post-lysine administration for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in level of 2-AAA in plasma

Change in level of 2-AAA in urine

Trial Design

1Treatment groups

Experimental Treatment

Group I: Participants administered oral lysineExperimental Treatment2 Interventions

participants will be administered 5g oral lysine

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Lysine

FDA approved

Normal Saline

2019

Completed Phase 4

~1770

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor

856 Previous Clinical Trials

672,169 Total Patients Enrolled

Jane Ferguson, PhDPrincipal InvestigatorVanderbilt University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals over 18 years of age accepted into this examination?

"To be considered for this trial, candidates need to be between 18 and 50 years old. For those who do not meet the age criteria there are 193 other trials that enrol patients younger than 18, as well 1066 studies suitable for individuals 65 or older."

Answered by AI

What are the qualifications for participating in this trial?

"Candidates between 18 and 50 years old with a diagnosis of type 2 diabetes mellitus may qualify for this medical trial. A maximum of 20 participants can join this research."

Answered by AI

How detrimental could the use of L-Lysine be to patients?

"Due to the limited data available and because this is a Phase 1 trial, L-Lysine's safety was rated as a score of 1."

Answered by AI

Is this scientific inquiry presently enrolling participants?

"According to clinicaltrials.gov, the trial is not currently recruiting subjects; however, it was initially posted on March 9th 2022 and last edited a few days later. Fortunately, 1392 other studies are actively seeking new patients at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3

Jane Ferguson 2022. "Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05210504.